SARS-CoV-2联疫苗引起强大的免疫反应,可以防止不断发展的变种
Melanie Carroll1, Heather B Fox2, Anh Tran3
1Viral Vaccines QC, Inventprise, Inc., Redmond, WA, USA.
Vaccine
|March 7, 2025
概括
新的联合疫苗显示了针对SARS-CoV-2令人担忧的变种 (VOC) 的广泛交叉中和. 这些高度免疫的疫苗提供了长期保护的潜力,不需要经常更新.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 病毒学 病毒学
背景情况:
- 引起关注的SARS-CoV-2变种 (VOC) 的出现对疫苗有效性构成重大挑战.
- 现有的疫苗往往难以提供持续的保护,防止像SARS-CoV-2这样快速变异的病毒.
研究的目的:
- 开发和评估能够引起针对SARS-CoV-2 VOC的广泛交叉中和的高度免疫原性联合疫苗.
- 评估这些新型候选疫苗提供的长期保护潜力.
主要方法:
- 使用蛋白质-蛋白质结合技术来增强疫苗免疫性.
- 纳入托尔类受体 (TLR) 激素辅助剂以促进免疫反应.
- 通过动物研究评估疫苗的疗效,包括中和抗体 (nAb) 标位和挑战模型.
主要成果:
- 与未结合的疫苗相比,结合疫苗显示出增强的免疫性.
- 候选疫苗诱导了针对多种SARS-CoV-2 VOC的广泛交叉保护,包括Beta,Delta和Omicron亚型.
- 鼠的nAb标位在各种VOC中保持一致,表明持续的疗效.
- 双对应合疫苗成功地预防了子挑战模型中的疾病.
结论:
- 蛋白质与蛋白质的结合与TLR激动剂辅助剂相结合,产生高度免疫的SARS-CoV-2疫苗.
- 这些疫苗提供广泛的对VOC的交叉保护,并有可能在不需要抗原适应的情况下扩展保护.
- 展示的技术适用于当前的SARS-CoV-2菌株和其他病毒病原体.
相关概念视频
02:50Conjugated Proteins
18.2K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.2K
01:30Cancer Vaccines
321
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
321
01:51Vaccinations
43.5K
Overview
43.5K
01:29Immune Response Against Viral Pathogens
724
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
724
00:42Cross-reactivity
30.9K
Overview
30.9K
01:03Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K